Olema Pharmaceuticals OLMA
NASDAQ OLMA
$8.18 -0.09 (-1.09%)
As of: Oct 2, 2026 · 2:18 PM EDT

Olema Pharmaceuticals (OLMA) Return on Assets [ROA] (2021 - 2026)

Updated

Olema Pharmaceuticals (OLMA) recorded Return on Assets [ROA] of -40.15% in Q2 2026, down 4.19 percentage points from -35.96% a year earlier and down 5.31 percentage points from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Olema Pharmaceuticals reported Return on Assets [ROA] of -33.01%, up 2.59 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for three straight years, though with a four-year change of -10.76 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -35.60% in FY2024 (+3.63 pp), -39.24% in FY2023 (+1.72 pp), -40.95% in FY2022 (-18.71 pp) and -22.25% in FY2021.
  • Quarterly Return on Assets [ROA] has ranged from -53.48% in Q1 2023 to -18.84% in Q3 2021 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] rose in four of the last eight quarters, with an average year-over-year change of +0.17 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 16.74 percentage points in Q1 2024, against a drop of 26.02 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -34.83% (Q1 2026), -36.68% (Q4 2025) and -40.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Olema Pharmaceuticals 755.59 Mn 755.59 Mn - -40.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.15%
Mar 31, 2026 -34.83%
Dec 31, 2025 -36.68%
Sep 30, 2025 -40.81%
Jun 30, 2025 -35.96%
Mar 31, 2025 -29.96%
Dec 31, 2024 -38.05%
Sep 30, 2024 -50.74%
Jun 30, 2024 -42.33%
Mar 31, 2024 -36.74%
Dec 31, 2023 -33.92%
Sep 30, 2023 -40.82%
Jun 30, 2023 -52.06%
Mar 31, 2023 -53.48%
Dec 31, 2022 -46.81%
Sep 30, 2022 -41.51%
Jun 30, 2022 -36.07%
Mar 31, 2022 -27.47%
Dec 31, 2021 -23.46%
Sep 30, 2021 -18.84%
API Access

Olema Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OLMA&period=max&api_key=YOUR_API_KEY